Agilent Technologies Acquires Developer of Microscopy Products for Life Sciences

Agilent Technologies Inc. today announced it has completed the acquisition of TILL Photonics GmbH, a developer, manufacturer and marketer of optical, fluorescence microscopy products for life sciences. Financial details were not disclosed.

Agilent announced the agreement to acquire TILL Photonics on March 3, 2008, at Pittcon.

TILL Photonics’ innovative, optical microscopes are used in fundamental research, applied science and diagnostics. The acquisition will complement Agilent’s atomic force microscope platform and is consistent with Agilent’s strategy of providing customers with comprehensive workflow solutions.

Headquartered in Munich, Germany, the company was founded in 1993 by Dr. Rainer Uhl, professor at the BioImaging Center of the University of Munich. TILL Photonics employees have now joined Agilent. More information about TILL Photonics is available at www.till-photonics.com.

TILL Photonics joins the recently formed Materials Science Solutions Unit (MSSU) within Agilent’s Life Science and Chemical Analysis business. MSSU’s focus is to provide microscopy, spectroscopy and particle analysis solutions for the materials testing, life sciences and chemical analysis markets, as well as to advance nanotechnology.

Agilent in Life Sciences

Agilent is the global leader in gas chromatography and gas chromatography/mass spectrometry, and liquid chromatography and liquid chromatography/mass spectrometry used to analyze the composition of air, water, food, drugs, industrial process streams and forensic evidence. The company is also a leading developer of hardware and software tools for life science analysis including genomics, proteomics and metabolomics. The company pioneered ink-jet in situ synthesis of nucleic acid microarray probes and microfluidic lab-on-a-chip Bioanalyzer and nano LC/MS applications that accelerate customer workflows.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.